Healthcare provider profile · identity verified

Eva Horvath, MD

Family Practice · WICHITA FALLS, TX · NPI 1922072214

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	132	39
Atorvastatin Calcium	Atorvastatin Calcium	118	36
Gabapentin	Gabapentin	114	29
Lisinopril	Lisinopril	86	28
Levothyroxine Sodium	Levothyroxine Sodium	84	25
Losartan Potassium	Losartan Potassium	81	17
Albuterol Sulfate Hfa	Albuterol Sulfate	73	27
Rosuvastatin Calcium	Rosuvastatin Calcium	73	27
Ozempic	Semaglutide	72	11
Omeprazole	Omeprazole	69	20
Potassium Chloride	Potassium Chloride	69	20
Pantoprazole Sodium	Pantoprazole Sodium	61	18
Metformin Hcl	Metformin Hcl	54	15
Metoprolol Succinate	Metoprolol Succinate	54	17
Spironolactone	Spironolactone	54	suppressed
Montelukast Sodium	Montelukast Sodium	48	17
Trazodone Hcl	Trazodone Hcl	48	13
Fluticasone Propionate	Fluticasone Propionate	43	15
Escitalopram Oxalate	Escitalopram Oxalate	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	11
Trulicity	Dulaglutide	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	13
Eliquis	Apixaban	33	suppressed
Simvastatin	Simvastatin	33	suppressed
Methocarbamol	Methocarbamol	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Furosemide	Furosemide	31	13
Jardiance	Empagliflozin	31	suppressed
Meloxicam	Meloxicam	31	11
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Pregabalin	Pregabalin	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Naproxen	Naproxen	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Atenolol	Atenolol	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Nystatin	Nystatin	13	suppressed
Belsomra	Suvorexant	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Topiramate	Topiramate	12	suppressed
Baclofen	Baclofen	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Euthyrox	Levothyroxine Sodium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error